277 Park Avenue,
New York , NY, 10172
New York , NY, 10172
Summary
The fund seeks to replicate the total return performance of the benchmark index, before fees and expenses, by investing in companies outside the United States.
The investment process starts with a list of companies in the benchmark index and the research team utilizes quantitative techniques and fundamental analysis to identify investment opportunities.
Next, the research team invests significantly in securities included in More
Webiste
Directors
Jan 16, 2024- Robert J. Grassi
- Raymond Kanner
- Kathleen M. Gallagher
- Frankie D. Hughes
- Gary L. French
- Stephen P. Fisher
- Dr. Robert A. Oden, Jr.
- John F. Finn
- Marilyn McCoy
- Marian U. Pardo
- Mary E. Martinez
- Nina O. Shenker
- Lawrence R. Maffia
- Robert F. Deutsch
- Thomas P. Lemke
- Emily A. Youssouf
Chief Compliance Officer
- Stephen M. Ungerman
Price
- $ 57.21 ( -6.66 )
-
Apr 04, 2025Last Close
- Net Assets
-
$6.4B
Mar 28, 2024
- 52-Week High/Low
- $64.6 - $55.2
- Expense Ratio
- -
Performance
YTD
0%
3 Year
3.1%
5 Year
213.65%
Best
223.83%
2021
Worst
-35.65%
2008
Company Name |
Holding |
| Novo Nordisk A/S | 4.08 % |
| ASML Holding NV | 3.33 % |
| Nestle SA | 2.41 % |
| AstraZeneca plc | 2.24 % |
| Shell plc | 2.1 % |
| Novartis AG | 2.07 % |
| SAP SE | 2.05 % |
| Roche Holding AG | 2.04 % |
| LVMH Moet Hennessy Louis Vuitton SE | 1.65 % |
| HSBC Holdings plc | 1.56 % |
| More | 1.56 % |
NAV
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BBEU | 0% | 8.6% | 16.7% | -15.8% | 223.8% | -30.5% | 20.5% | -33.1% | 10.2% | -1.5% | |
| S&P 500 | -13.7% | 23.3% | 24.2% | -19.4% | 27.3% | 16.2% | 28.9% | -6.2% | 19.4% | 9.5% |
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| q1 | 0% | 4.9% | 10.1% | -4.7% | 164.6% | -25.2% | 11% | 0% | 0% | 0% | ||||
| q2 | 0% | -3.3% | 1.4% | -16% | 13.3% | 15.8% | 1.1% | -0.7% | 0% | 0% | ||||
| q3 | 0% | 0% | -6.1% | -12.5% | 12.7% | 154% | -2.8% | 1.4% | 0% | 0% | ||||
| q4 | 0% | 0% | 13.2% | 20.3% | -1.9% | -68.4% | 8.8% | -12.7% | 0% | 0% |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| 2024 | -0.9% | 2.6% | 3.3% | -2.4% | 4.1% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |